Audits and Vendor Qualifications

At Ardent Clinical Research Services, quality, integrity, and regulatory compliance are deeply embedded into every aspect of our operations. Our internal quality assurance systems are designed to meet international regulatory standards, and we regularly undergo vendor qualification audits from leading pharmaceutical, biotech, and nutraceutical companies across the globe.

We maintain robust audit readiness and have successfully passed numerous compliance audits, facility inspections, and capability assessments by both domestic and international sponsors.

We Are Proud to Be Qualified By the Following Esteemed Sponsors:

Shilpa Medicare Pvt. Ltd

Shilpa Medicare Pvt. Ltd

MSN Laboratories

MSN Laboratories

BIOCON

BIOCON

Eris Life Sciences Ltd

Eris Life Sciences Ltd

Glenmark Pharmaceuticals

Glenmark Pharmaceuticals

Gufic Biosciences

Gufic Biosciences

Hetero Labs

Hetero Labs

Nutureceuticals (Malaysia)

Nutureceuticals (Malaysia)

Onkokocsel (Turkey)

Onkokocsel (Turkey)

Pharmasyntez (Russia)

Pharmasyntez (Russia)

RK Pharma (New York, USA)

RK Pharma (New York, USA)

SP Accure Labs

SP Accure Labs

Wielding Pharma (Germany)

Wielding Pharma (Germany)

Arjuna Naturals

Arjuna Naturals

Bilcare

Bilcare

Cohance Lifesciences

Cohance Lifesciences

Our Audit Preparedness Includes:

  • Dedicated Quality Assurance (QA) team
  • Regular internal audits and mock inspections
  • Controlled and documented SOP environment
  • Real-time CAPA tracking and resolution
  • Proactive risk management and mitigation planning
  • 24/7 access to trained personnel and facilities for sponsor or regulatory inspections

Being qualified by this diverse range of reputed sponsors across pharma, biotech, medical devices, and herbal/nutraceutical sectors is a testament to our global standards, compliance culture, and commitment to excellence in clinical research delivery.

We continue to welcome and successfully clear audits by new sponsors and regulatory bodies to expand our collaborations globally.